Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology

Barry J. Maron, James E. Udelson, Robert O. Bonow, Rick A. Nishimura, Michael J. Ackerman, N. A.Mark Estes, Leslie T. Cooper, Mark S. Link, Martin S. Maron

Research output: Contribution to journalArticle

86 Scopus citations
Original languageEnglish (US)
Pages (from-to)2362-2371
Number of pages10
JournalJournal of the American College of Cardiology
Volume66
Issue number21
DOIs
StatePublished - Jan 1 2015

Keywords

  • ACC/AHA Scientific Statements
  • arrhythmogenic right ventricular cardiomyopathy
  • athletes
  • cardiomyopathy
  • cardiovascular abnormalities
  • cardiovascular magnetic resonance
  • hypertrophic cardiomyopathy
  • myocarditis
  • sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this